Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Sadif Analytics (Premium)
$10.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Auxilium Pharmaceuticals Inc lowers FY 2014 guidance


Tuesday, 29 Apr 2014 07:05pm EDT 

Auxilium Pharmaceuticals Inc:Revises FY 2014 guidance.Sees FY 2014 total revenues between $380 - $420.Sees FY 2014 non-GAAP Net Income (Loss) of between $0 - $(15). 

Company Quote

18.47
-0.08 -0.43%
22 Aug 2014